Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Direct Link to the Sativa Homepage for the document:
https://sativawellnessgroup.com/agm-sept-16-2021/
choose:
SATIVA Management Information Circular AGM 21
Hi guys,
since yesterday the detailed information for the AGM on 16 September at 9 a.m. PST (5 p.m. UK | 6 p.m. Germany) are available.
In the meeting the following items are for voting:
1. to receive the financial statements of the Company for its fiscal year ended December 31, 2020
2. to set the number of directors of the Company for the ensuing year at six (6);
3. to elect the directors of the Company for the ensuing year;
4. to appoint RSM Canada, 11 King St. W., Suite 700, Box 27, Toronto, Ontario, M5H 4C7, as auditors of the
Company and to authorize the directors of the Company to fix the auditors remuneration;
5. to approve the Company’s stock option plan, as described in the accompanying management information
circular; and
6. to transact such other business, including amendments to the foregoing, as may properly come before the
Meeting or any adjournment or adjournments thereof.
In addition, there will be an opportunity for unregistered shareholders to share and ask questions. So take advantage of this opportunity.
All information can be found in the document at sedar.com (just search for the company)
https://vimeo.com/341885818. Watch the video of Frabrice Taylor. 3 minutes in. Explains that at one point Stillcanna was valued at 300m and also where the 24m was raised from. Not sure if the link will work but again its on you tube. Gerermy has said the time is not quite right to re enter the market for cbd but when they do it will be with force. He is a smart guy. Cbd stocks are falling at the moment and with someone like OCTP being 44% down over the last 6 months there are bargains to be had. We are in a strong position for this as we are cash rich.
Sativa is a small fish in a big pond where covid testing is concerned. They are also charging more than most at a time when the government are looking to crack down on the pricing structure. Not something to shout about for Sativa at this point. I agree if they had 20m it would be seen in the accounts. However, there has never been a mention of the business or contracts that were brought across with Stillcanna or what the cash figure was. This needs to be explained. It is clear though that they are generating cash and they are looking to move in on the cbd market with some force. The next avenues for them in the cbd market appears to be vapes and drinks as explained in their press release. When covid struck Sativa moved into hand sanitiser. When the restaurants closed Sativa moved into covid testing. When covid testing is no longer required I expect the Company will move on to something else. The potential is massive. Frustratingly slow tho..
The 24 million are probably still thoughts from 2019 in connection with the sale of Olimax. If Sativa had that much cash, the money would have to be reported in the Q2 Fins 2021. There is £3.6m in the Q2 Fins 2021.
In the video from June, Geremy only explains why it currently makes no sense to advertise CBD products.
But why the news are not currently shared on any of the relevant websites or why the testing possibilities of the Covid clinics are not local advertised is left out.
From my point of view and that of many other German shareholders, there is not enough drive behind it. The currently very good news are being burned and are losing a lot of its impact because the company cannot promote itself properly.
I agree, it is good to have new contributors on here. Watch the LSE video on you tube of Geremy. 22 mins. He explains the marketing issue well. The company has really slowed up with the opening of clinics, but they are pretty often ahead of the curve so that does not bother me. What bothers me is if they decide to acquire someone else and us as shareholders suffer for it. However, Geremy has stated that he was attracted to the cash in Stillcanna. Stillcanna raised 24 m ( Having watched previous Stillcanna material on you tube). So if the company is sitting on this cash we could see a big acquisition on the cards. It also means that we are worth at least double the market cap at the moment. I believe firmly in this team
Of course, that is not so pleasant. I have already heard about the dilution. What exactly do you mean by a reverse takeover? Was there ever a reverse split? I don't know anything about that. I had only heard that the number of shares was massively increased in order to be able to carry out financing. I was only made aware of Sativa about 6 weeks ago and immediately recognised its incredible potential. From my point of view, there are currently three big issue which need to be solved:
- Expansion of the CovidTest clinics into the north of the UK
- CBD distribution including the associated figures
- Marketing of the whole company and the lack of local, regional advertising for the CovidTest clinics, as there is so much potential there at the moment
Lebadinho, nice to have you on board here. This has been an issue for so long. We get lots of positivity, but never reflected in the price. When Sativa started out as Sativa Investments, the volume was massive and SP went as high as 15p I think. Since then, it has fallen flat. There is a good number of us here that have been in since the inception. However, we are all massively under water due to the reverse takeover and two thirds dilution. That coupled with the great expense to actually buy the shares, means very flat volumes and a general lack of interest. Thanks for your work, something need to change and quickly.
Sativa Wellness Group Announces German Distribution Agreement for Goodbody Brand
Tuesday, August 24, 2021 7:01 AM
VANCOUVER, BC / ACCESSWIRE / August 24, 2021 / Sativa Wellness Group Inc. (CSE:SWEL) ("Sativa Wellness" or the "Company") is pleased to announce today that it has signed a distribution agreement with German partners Lexamed GMBH ("Lexamed"). This exclusive agreement will allow both parties to work together to build the Goodbody CBD brand within Germany with plans to expand this to other European countries in the future. The German market has a strong CBD market, and this is a great opportunity for both companies. The existing Goodbody range will be offered through a number of channels in Germany and the companies will also work together to develop new products for the European market in conjunction with Sativa Wellness's polish extraction and manufacturing facility.
Sativa Group Limited and Lexamed currently share ownership of a joint venture company, Sativa GMBH. As part of this agreement the Company will transfer full ownership of Sativa GMBH to Lexamed and Sativa GMBH will be renamed as Lexalife GMBH ("Lexalife"). Lexalife will act as the distribution partner in Germany for Goodbody Botanicals Limited, Sativa's CBD production and distribution subsidiary.
Geremy Thomas, Executive Chairman, says; "We are really excited about this new development with an existing partner which opens up so many opportunities and helps Sativa to deliver its strategic plan of increasing our footprint in Europe."
News for myesterday - couldn't share the link
Sativa Wellness Group Announces German Distribution Agreement for Goodbody Brand
Tuesday, August 24, 2021 7:01 AM
VANCOUVER, BC / ACCESSWIRE / August 24, 2021 / Sativa Wellness Group Inc. (CSE:SWEL) ("Sativa Wellness" or the "Company") is pleased to announce today that it has signed a distribution agreement with German partners Lexamed GMBH ("Lexamed"). This exclusive agreement will allow both parties to work together to build the Goodbody CBD brand within Germany with plans to expand this to other European countries in the future. The German market has a strong CBD market, and this is a great opportunity for both companies. The existing Goodbody range will be offered through a number of channels in Germany and the companies will also work together to develop new products for the European market in conjunction with Sativa Wellness's polish extraction and manufacturing facility.
Sativa Group Limited and Lexamed currently share ownership of a joint venture company, Sativa GMBH. As part of this agreement the Company will transfer full ownership of Sativa GMBH to Lexamed and Sativa GMBH will be renamed as Lexalife GMBH ("Lexalife"). Lexalife will act as the distribution partner in Germany for Goodbody Botanicals Limited, Sativa's CBD production and distribution subsidiary.
Geremy Thomas, Executive Chairman, says; "We are really excited about this new development with an existing partner which opens up so many opportunities and helps Sativa to deliver its strategic plan of increasing our footprint in Europe."
Hi guys,
I am a German investor in Sativa and have looked at the lack of external representation together with other German investors. We have analysed a lot.
We then sent this info to Sativa. Among other things, things like: News sharing in the UK on relevant stock exchange portals via ShareCast, in Germany via dpa and irw. In addition, we also noted that news sharing on LSE and hargraeves lansdown is essential for Sativa to become better known in the UK market. We have pointed out deficits in external presentation and marketing. Also deficiencies in trading in the UK. That Sativa is not listed with all relevant brokers.
So far we have always received direct feedback from Anne Tew (CFO & Chief of Comm). They are working on changing this. Let's hope it happens quickly. Because all the news this year should have caused the share price to rise long ago.
The more these points are pointed out at Satvia, the more pressure there will be for them to change something.
NEWS from yesterday
https://www.accesswire.com/661022/Sativa-Wellness-Group-Announces-German-Distribution-Agreement-for-Goodbody-Brand
Needs Aquis to sort out the HL issue of having to phone through orders or we need to move to AIM. Either way, there is only good news coming with Sativa.
More updates and positivity here again this morning and not a flinch in the volume or share price...what is going on here?!
Paid 4.15. Purchase after mine was at 4. Maybe I was not buying from MM but HL. The sooner we get into the 21st century with this stock the better for all concerned. I will not buy any more until we have a proper trading platform.
Urars=years
Same with me when i bought a few urars ago. Was it still £30?
Paid over the odds today due to the fact that I have to phone through my orders. HL very disappointing. Thankfully the last of my orders.
23 July 2021
Sativa Wellness announces Strong position and Clear Strategy
Sativa Wellness is pleased to announce its new business strategy following a strong start to the year.
Highlights for first half of 2021
· Change in leadership with the founder returning as Chair and a strong top team appointed.
· The Wellness business aligned in three clear divisions as CBD products, Cannabinoid testing and Clinic Testing Services each with a clear business head.
· Q1 the best quarterly turnover to date for any quarter since Sativa Wellness and its predecessor Sativa Group Plc started in 2018 at £1.37m.
· Q2 produced even stronger revenue results with full results for the first 6 months to be reported in August.
· The business is operating on a positive cash flow, and is maintaining a healthy cash position to further its acquisition strategy.
· The main trading company Goodbody Botanicals has generated profits year to date in 2021, from a loss-making position in previous years.
· The novel food submission submitted on time, full acceptance is still in progress.
· ISO 17025 achieved by the Phytovista Laboratory for cannabinoid testing.
· Roll out of 47 COVID testing clinics to build the newest division of the business.
· Successful placement to invest in the future business.
Strategic direction
The business will align the legal entities within the Group with the divisions as laid out above separating clinic testing from CBD so clearer reporting will be available in 2022. The plans we have in place and are progressing include:
CBD Products-Goodbody Brand
· Secure sales through well-known online platforms.
· Build a 'membership' model for CBD to build predictable revenues.
· Extent product range to include drinks and vape.
· Secure distribution agreements with partners throughout Europe.
· Progress merger and acquisitions to increase the product range and revenue.
· Expand the production of an increased range in Poland.
Cannabinoid Testing
· Expanding the scope of the ISO17025 accreditation.
· Work with the Polish laboratory team to expand cannabinoid testing in Europe.
· Position the business to partner with institutions as a key supplier.
Clinic Services
· Significantly increase the footprint of clinics across the UK.
· Expand COVID 19 testing, incorporating Influenza A&B and RSV.
· Introduce a range of wellness testing through the clinic network.
· Introduce technical solutions for faster testing.
· Introduce corporate testing.
Geremy Thomas, Executive Chairman, says; "It has been six months since I felt compelled to take back leadership of Sativa and I am pleased to say the changes made have produced strong results both financially and operationally. The next phase will be exciting for us all."
Marc Howells, Chief Executive Officer, says "I am delighted to join such an exciting Company
Geremy........been a long time coming but I have faith...
Didn't Sadiq Khan promise a referendum on legalising Cannabis in London if he got voted in again?
He was the one that changed the legislation for cannabis back in 2018 was it? which then put sativa on the map? Interesting times...
MPBUK,as you say most of us will be well under water from the reverse takeover shafting , I can’t afford to write off 66 % losses but I’m certainly not putting any more in until that issue is addressed by the board and also they come off AQUIS which costs £20 a telephone trade on HL . However , The news flow seems quite positive recently since new CEO took over so I’m a bit more optimistic now